Gary Hattersley, CHIEF SCIENTIFIC OFFICER at Nuvation Bio Inc. (NUVB), sold 100,000 shares at $7.09 ($709K) on 2026-08-19, disclosed to the SEC on 2026-08-21.
Scheduled sale ($709k) by CHIEF SCIENTIFIC OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RDUS | SELL | 2015-11-13 | $426K | — | Filing → |
| RDUS | SELL | 2015-11-05 | $933K | — | Filing → |
| RDUS | SELL | 2015-10-27 | $735K | — | Filing → |